SCHEMBL30906446

CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C

nearest known ligand 0.69

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	11/20	0.63

▸	GCGR	P47871	4/20	0.63

▸	NPY1R	P25929	1/20	0.61

▸	NPY2R	P49146	1/20	0.61

▸	NPY4R	P50391	1/20	0.61

▸	NPY5R	Q15761	1/20	0.61

▸	IL23R	Q5VWK5	3/20	0.61

▸	GIPR	P48546	1/20	0.60

▸	CXCR4	P61073	2/20	0.60

▸	CCKBR	P32239	1/20	0.59

▸	CALCR	P30988	1/20	0.59

▸	ECE1	P42892	1/20	0.58

▸	MUS81	Q96NY9	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31000901	1.00	GLP1R (0.63)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906374	1.00	GLP1R (0.63)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906341	1.00	GLP1R (0.63)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906365	1.00	GLP1R (0.63)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906550	0.99	GLP1R (0.61)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906412	0.98	GLP1R (0.65)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906401	0.98	GLP1R (0.65)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906504	0.97	GLP1R (0.66)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906372	0.95	GLP1R (0.64)	GLP1RGCGRNPY1RNPY2RNPY4R
SCHEMBL30906434	0.95	GLP1R (0.67)	GLP1RGCGRGIPRCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed